Stockreport

ARCA Biopharma gets Fast Track designation for experimental COVID-19 treatment [MarketWatch]

ARCA biopharma, Inc.  (ABIO) 
US:NASDAQ Investor Relations: arcabio.com/investors
PDF Shares of ARCA Biopharma Inc. gained 5.5% in trading on Monday after the company said it received a Fast-Track designation from the Food and Drug Administration for its [Read more]